cobas® Strep A Assay 

We put a lab in a tube...

The cobas® Strep A nucleic acid test for use on the cobas® Liat System (cobas® Liat Strep A) is a qualitative in vitro diagnostic test for the detection of Streptococcus pyogenes (Group A β-hemolytic Streptococcus,  Strep  A)  in  throat  swab  specimens  from  patients  with  signs  and  symptoms  of pharyngitis. The cobas® Liat Strep A Assay utilizes nucleic acid purification and polymerase chain reaction (PCR) technology to detect Streptococcus pyogenes by targeting a segment of the Streptococcus pyogenes genome.

The cobas® Strep A nucleic acid test, for use on the cobas® Liat® System, is a qualitative in vitro diagnostic test for the detection of Streptococcus pyogenes (roup A β-hemolytic Streptococcus, Strep A) in throat swab specimens from patients with signs and symptoms of pharyngitis. The cobas® Liat® Strep A Assay utilizes nucleic acid purification and polymerase chain reaction (PCR) technology to detect Streptococcus pyogenes by targeting a segment of the Streptococcus pyogenes genome.

Features and Benefits

  • Small: The compact cobas® Liat® benchtop analyzer is smaller than a shoebox and conveniently designed for space-challenged testing locations
  • Simple: The cobas® Liat® System is fully-automated with touchscreen guided operation, requiring minimal training and hands-on time. Add nothing more than a patient sample.
  • Swift: Sample to results in 20 minutes or less. Single assay runs allow time-sensitive testing and reporting.
  • Secure: Sealed-tube design eliminates operator contact with reagents or other chemicals. Closed system with multiple controls reduce the potential for human error.

Intended Use

The cobas® Strep A Assay is a designed for on-demand testing in point-of-care* settings such as physician clinics, pharmacy, and hospital and satellite laboratories.

* CE-IVD, 510(k) cleared and CLIA-waived. The cobas® Liat System is not commercially available in all markets.